Radiopharmaceuticals Market Research Reports & Industry Analysis
A radiopharmaceutical, which involves the use of radioactive agents in vivo to diagnose or treat specific diseases and conditions, generally consists of two components which determine its characteristics and clinical potential. The most common diagnostic molecular imaging agents use radioactive isotopes as the signal source. A radioactive isotope -- a radioisotope or radionuclide -- is a natural or artificially created isotope with an unstable nucleus that decays -- emitting alpha or beta particles, positrons, or gamma rays. As it decays, it loses mass and energy, until a stable isotope develops. For most elements, both stable and radioactive isotopes are known.
Examples of radioisotopes commonly combined with pharmaceutically-active molecules to form radiopharmaceuticals include technetium-99m, gallium-67, Iodine-123, Iodine-13, Thallium-201, Fluorine-18, and Indium-111.
A number of SPECT radiopharmaceuticals incorporate antibody and peptide formulations that can be targeted to specific tissue receptors, allowing one to discriminate healthy from diseased tissue with a high confidence level. However, the more specific the targeting agent is, the more difficult it is to interpret its position anatomically, since there are fewer landmarks.
Radiopharmaceuticals Industry Research & Market Reports
-
Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2024(Status and Outlook)
... radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide. The Global Radiopharmaceuticals in Nuclear Medicine Market Size was estimated at USD 5225.65 million in 2023 and is projected to reach ... Read More
-
Global Radiopharmaceutical Theranostics Market Research Report 2024(Status and Outlook)
... of a therapeutic strategy to cure, alleviate, or control the disease. The Global Radiopharmaceutical Theranostics Market Size was estimated at USD 776.79 million in 2023 and is projected to reach USD 988.57 million by 2029, ... Read More
-
Global Diagnostic Radiopharmaceuticals and Contrast Media Market Research Report 2024(Status and Outlook)
... reach USD 9797.43 million by 2029, exhibiting a CAGR of 3.20% during the forecast period. This report provides a deep insight into the global Diagnostic Radiopharmaceuticals and Contrast Media market covering all its essential aspects. ... Read More
-
Positron Emission Tomography Market Forecasts to 2030 – Global Analysis By Product (Radiotracers, Positron Emission Tomography (PET) Scanners, Radiopharmaceuticals and Other Products), Application, End User and By Geography
... Emission Tomography Market is accounted for $1.5 billion in 2023 and is expected to reach $2.7 billion by 2030 growing at a CAGR of 8.6% during the forecast period. A nuclear medicine and biochemical analysis ... Read More
-
Europe Nuclear Medicine Market, By Type (Diagnostic (SPECT, PET)), Therapeutic (Beta Emitters, Alpha Emitters))); By Application (Diagnostic (SPECT, PET)), Therapeutic (Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Others)); By Procedural Volumes (Diagnostic (SPECT Radiopharmaceuticals, PET Radiopharmaceuticals)), Therapeutic (Beta Emitters, Alpha Emitters, Brachytherapy)); By Country (Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, Netherlands, Rest of Europe), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of MEA), Trend Analysis, Competitive Landscape & Forecast, 2019–2029 Europe Nuclear Medicine Market Size almost Doubles at Robust CAGR of 12.03% during 2023–2029, ... Read More
-
Global Radiopharmaceutical Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... the Radiopharmaceutical industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Radiopharmaceutical. The report also introduces players in the industry from the perspective ... Read More
-
France Nuclear Medicine Market By Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), By Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals, PET Radiopharmaceuticals), By Therapeutic Nuclear Medicine (Beta Emitters, Alpha Emitters, Brac
... Others {Respiratory, Musculoskeletal System Diseases, Thyroid, etc.}), By End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutions, Others {Pharmaceutical Companies, Ambulatory Centers etc.}), By Region, By Competition Forecast & Opportunities, 2018-2028F France Nuclear ... Read More
-
South & Central America Radiopharmaceutical Theranostics Market Forecast to 2028 - Regional Analysis - by Product Type (Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers), Radioisotope (Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others); Source (Nuclear Reactors and Cyclotrons), Application (Targeted Therapeutic [Rx] and Companion Diagnostic [CDx]); Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others); Source (Nuclear Reactors and Cyclotrons), Application (Targeted Therapeutic [Rx] and Companion Diagnostic [CDx]); Indication (Oncology, Cardiology, Neurology, and Others), and End User ... Read More
-
Middle East & Africa Radiopharmaceutical Theranostics Market Forecast to 2028 - Regional Analysis - by Product Type (Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers), Radioisotope (Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others); Source (Nuclear Reactors and Cyclotrons), Application (Targeted Therapeutic [Rx] and Companion Diagnostic [CDx]); Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others); Source (Nuclear Reactors and Cyclotrons), Application (Targeted Therapeutic [Rx] and Companion Diagnostic [CDx]); Indication (Oncology, Cardiology, Neurology, and Others), and End User ... Read More
-
Global Radiopharmaceutical Injector Market Growth 2023-2029
... Radiopharmaceutical Injector is forecast to a readjusted size of US$ 45 million by 2029 with a CAGR of 7.6% during review period. The research report highlights the growth potential of the global Radiopharmaceutical Injector market. ... Read More
-
Global Radiopharmaceutical Injector Supply, Demand and Key Producers, 2023-2029
... period (2023-2029). Global key players of Radiopharmaceutical Injector include Medrad, Inc.(Bayer), UNIVERSAL GIKEN and Comecer, etc. The top three players hold a share over 65%. Medrad, Inc.(Bayer) is the largest manufacturers of Radiopharmaceutical Injector in ... Read More
-
Global Radiopharmaceutical Injector Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... 2022 and is forecast to a readjusted size of USD 45 million by 2029 with a CAGR of 7.0% during review period. A radiopharmaceutical injector is a medical device used to administer radiopharmaceuticals to patients. ... Read More
-
Diagnostic Radiopharmaceuticals and Contrast Media Market Outlook to 2030- Forecasts of Market Size, Share, Companies, Countries, Trends, Opportunities, and Industry Developments Report
... the market size poised to register an optimistic growth between 2024 and 2030. Robust demand from end-user industries, widening applications, and investments in new technologies support the long-term market growth potential. The late-2023 edition- “Diagnostic ... Read More
-
Radiopharmaceutical Theranostics Global Market Report 2023 Including: 1) By Product Type: Alpha Emitters; Beta Emitters; Positron Emission Tomography (PET) Tracers 2) By Source: Nuclear Reactors; Cyclotrons 3) By Radioisotope: Technetium-99; Gallium-68; Iodine-131; Iodine-123; 18F; Y-90; Lutetium (Lu) 177; Copper (Cu) 67; Copper (Cu) 64 4) By Indication: Oncology; Cardiology; Neurology 5) By End User: Hospitals; Diagnostic Imaging Centers; Academic And Research Institutesrs Covering: Cardinal Health Inc.; AstraZeneca Plc; GE HealthCare Technologies Inc.; Bayer AG; China Grand Pharmaceutical & Healthcare.
... 177; Copper (Cu) 67; Copper (Cu) 644) By Indication: Oncology; Cardiology; Neurology5) By End User: Hospitals; Diagnostic Imaging Centers; Academic And Research InstitutesrsCovering: Cardinal Health Inc.; AstraZeneca Plc; GE HealthCare Technologies Inc.; Bayer AG; China ... Read More
-
Global Targeted Radiopharmaceuticals Market Growth 2023-2029
... from influence of COVID-19 and the Russia-Ukraine War, the Targeted Radiopharmaceuticals is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. The research report highlights the ... Read More
-
Global Radiopharmaceuticals Dispensing System Market Growth 2023-2029
... and recovery from influence of COVID-19 and the Russia-Ukraine War, the Radiopharmaceuticals Dispensing System is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. The research ... Read More
-
Global Automatic Dispenser for Radiopharmaceuticals Market Growth 2023-2029
... downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Automatic Dispenser for Radiopharmaceuticals is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review ... Read More
-
Global SPECT and PET Radiopharmaceuticals Market Growth (Status and Outlook) 2023-2029
... growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the SPECT and PET Radiopharmaceuticals is forecast to a readjusted size of US$ million by 2029 with a CAGR of ... Read More
-
Global Cardiology Radiopharmaceuticals Market Growth (Status and Outlook) 2023-2029
... market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Cardiology Radiopharmaceuticals is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. The research ... Read More
-
Global Nuclear Medicine & Radiopharmaceuticals Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
... and provide diagnostic information about specific organ functions. Therapeutic radioisotopes are used to treat medical diseases, especially cancer, and they use radiation to destroy or weaken specific target cells. It includes therapeutic and diagnostic technologies ... Read More
-
Diagnostic Radiopharmaceuticals Industry Research Report 2023
... the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases. Highlights The global Diagnostic Radiopharmaceuticals market ... Read More
-
Europe Radiopharmaceuticals Market - Industry Trends and Forecast to 2030
... during the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030. Market ... Read More
-
Global Radiopharmaceutical Injector Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
... a CAGR of 7.35% during the forecast period (2023-2029). The global key manufacturers of Radiopharmaceutical Injector include Medrad, Inc.(Bayer), UNIVERSAL GIKEN, Comecer, Sumitomo Heavy Industries, Tema Sinergie, Lemer Pax, BQSV, and etc. In 2022, the ... Read More
-
Global Theranostics Market - 2023-2030
... is to exhibit a CAGR of 11.3% during the forecast period (2023-2030). Theranostics is a combination of the terms therapeutics and diagnostics. Theranostics is the term used to describe the combination of using one radioactive ... Read More
-
Global Radiopharmaceutical Theranostics Market Report and Forecast 2023-2031
... the need for effective and precise treatment options across the globe. The market size is anticipated to grow at a CAGR of 13.8% during the forecast period of 2023-2031 to achieve a value of USD ... Read More
Research Assistance
